Peggy Scherle

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

PRLD

Current role

1 call Latest call 2025-11-12

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2025	Prelude Therapeutics Inc (PRLD)	Ph. D. Chief Scientific Officer	$473,416	—	—	$145,523	$190,440	$10,350	$819,729
2022	Prelude Therapeutics Inc (PRLD)	Chief Scientific Officer	$416,667	$300,000	—	$761,865	$142,800	$9,150	$1,630,482
2021	Prelude Therapeutics Inc (PRLD)	Chief Scientific Officer	$408,271	—	—	$2,068,828	$156,000	$8,700	$2,641,799
2020	Prelude Therapeutics Inc (PRLD)	Chief Scientific Officer	$347,865	—	—	$2,170,824	$171,552	—	$2,690,241

Earnings-call appearances and filed executive appointments or departures, newest first.